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Diabetes and Breast Cancer Survivorship: A Case Report 
The breast cancer survivor community continues to expand with improved breast cancer 
screening and treatment. Female breast cancer survivors with a comorbid diagnosis of type 2 
diabetes are at higher risk for morbidity, mortality and decreased quality of life than other breast 
cancer survivors. A 45-year-old Caucasian female, with significant past medical history of type 2 
diabetes and hypertension, presented to the primary care clinic for evaluation regarding diabetic 
follow-up. She admitted to lack of follow-up regarding her diabetes, poor dietary choices and a 
sedentary lifestyle. A collaborative approach was taken in the care of this patient to assure 
improved outcomes and to reinforce necessary lifestyle changes. Survivorship care of diabetic 
breast cancer survivors should focus on effective diabetes management, identification of 
modifiable lifestyle factors, medication compliance and supporting positive health changes. 
While additional research is required, future interventions must incorporative the entire treatment 
team, including primary care providers and oncology specialists, in a coordinated effort to 
improve breast cancer survivor quality of life and long-term outcomes. Lifestyle intervention 









TYPE 2 DIABETES AND BREAST CANCER SURVIVORSHIP: A CASE REPORT 3 
Introduction 
 The continuous advancements in breast cancer screening and treatment coupled with an 
aging society has resulted in a persistent expansion of the breast cancer survivor community 
(Vissers, Falzon, van de Poll-Franse, Pouwer, & Thong, 2016). More than 3.5 million women in 
the United States have are living with a history of breast cancer (American Cancer Society, 
2017). The relative five-year survival rate for female breast cancer is near 90% with almost 
100% 5-year relative survival rate for stage 1, localized, breast cancer (Howlander et al., 2017).  
The incidence of type 2 diabetes in cancer survivors is higher than that of the general population 
(Onitilo et al., 2013). Chronic conditions diagnosed in the cancer survivor are associated with 
increased health care use, medical costs and loss of productivity (Guy et al., 2017; Heins, 
Korevaar, Rijken & Schellevis, 2012). The purpose of this case report is to identify current 
evidence regarding best practices in the care diabetic breast cancer survivors (BCS). This paper 
will present necessary background information on the topic, a related case report, current 
literature review, synthesis and recommendations for future research.  
Background 
 In general, survivors of cancer are more likely to suffer from chronic conditions than an 
individual without a history of cancer (Guy et al., 2017). Long-term cancer survivors are at 
increased risk for type 2 diabetes, cardiovascular disease, overweight and obesity, chronic pain, 
fatigue and poor health-related quality of life (Conlon et al., 2015). Unique considerations and 
management interventions are required to improve survivorship care, including physical and 
emotional heath promotion, in the growing population of BCS. While survivorship should be 
much celebrated in the arena of breast cancer treatment, the long-term health, economic and 
psychosocial implications must not be overlooked. The known long-term effects of the breast 
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cancer diagnosis highlight the importance of improving survivorship care through intensified 
screening, surveillance and chronic disease management (Guy et al., 2017).  
 While the community of cancer survivors continues to grow, finding a universally 
accepted definition for the concept of “cancer survivorship” has proved difficult. For the purpose 
of this case report, the content is directed towards the individual in “permanent survivorship”; 
when cancer treatment is completed, recurrence is not likely and focus is on the long-term effects 
of cancer and its treatment (American Society of Clinical Oncology, 2016). In addition, this case 
report focuses on female BCS, recognizing these results may not be generalizable to male BCS.  
 While both cancer and diabetes share many similar risk factors including aging, obesity, 
diet and physical inactivity, the association between the two disease states has yet to be fully 
elucidated (Paxton, Taylor, Chang, Courneya, & Jones, 2013). Potential direct links between the 
diagnosis of diabetes and cancer include hyperinsulinemia, hyperglycemia and inflammation 
(Onitilo et al., 2013). The association may also be related to cancer treatment, age and/or 
unhealthy lifestyle choices (obesity and sedentary lifestyle) (Onitilo et al., 2013; Lipscombe et 
al., 2013; Weaver et al., 2013). Regardless, cancer survivors with diabetes represent a vulnerable 
population who may benefit from increased screening and treatment of comorbidities, as well as 
promoting a healthy lifestyle. A current review of the literature regarding the diagnosis of type 2 
diabetes in BCS was conducted in order to identify best practices in providing survivorship care 
to this patient population.   
Case Report 
 A 45-year-old Caucasian female, with significant past medical history of type 2 diabetes 
and hypertension, presented to the clinic for a chief complaint of “diabetes follow-up”. She 
reported she saw the diabetes educator last week and was encouraged to come in for follow-up. 
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She presented with concerns regarding a 20-pound weight gain over the course of a year and 
fatigue for the last six months. She stated a known diagnosis of type 2 diabetes, however 
admitted to being inconsistent in her follow-up for her diagnosis. She noted she was diagnosed 
“a few years ago,” and at that time, she was started on oral Metformin 500 mg twice daily. She 
reported taking this medication consistently. Family history was significant for a myocardial 
infarction in her father at age 50. 
 In regards to her weight gain, the patient felt this was appropriate given her recent poor 
dietary choices and inactivity. She denied any shortness of breath, edema or decreased urine 
output. Her additional symptom of fatigue was quite nonspecific. Discussion included sleep 
hygiene, limiting caffeine/alcohol intake as well as improving her glycemic control as 
interventions to help with her symptoms of fatigue. 
 The patient’s vital signs revealed moderate hypertension at 148/98, a normal pulse, 
respiratory rate and temperature. Her medications included Metformin 500 mg twice daily, 
aspirin 81 mg daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily and a multivitamin. Upon 
further questioning, she reported she stopped taking her Lisinopril “a while ago” due to the 
commonly experienced side effect of cough. Otherwise, the patient was medication compliant. 
Physical exam was benign, with the exception of some new onset of bilateral decreased sensation 
to her feet. She denied any pain, numbness or tingling with this new onset neuropathy. 
Laboratory tests performed included hemoglobin A1c, basic metabolic panel, thyroid stimulating 
hormone, free t4 and lipid panel.  Hemoglobin A1c was elevated at 8.5, and other results were 
within expected limits. 
 These results were reviewed with the patient. This patient required improved blood 
pressure management, and thus was started on an angiotensin receptor blocker in hopes to avoid 
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the symptoms of cough she was experiencing. She also required intensified management of her 
diabetes. She was instructed to increase her Metformin from 500 mg twice per day to 1000 mg 
twice per day. She was instructed to continue her statin medication as well as a baby aspirin. She 
was in agreement with this plan.  
 The patient was also advised to follow-up with the diabetic educator and dietician. She 
has multiple areas for improvement in her lifestyle behaviors that could result in improved 
diabetes management and decrease in cardiovascular risk. The patient was educated generally on 
the importance of following a diabetic diet and incorporating activity into her daily routine. She 
has historically not followed through with routine diabetic follow-up appointments. She is 
educated on the need to be seen on a consistent basis in order to assure glycemic control, 
medication compliance and maintenance of healthy lifestyle changes.  
Literature Review 
 Optimal long-term management of type 2 diabetes in BCS requires the identification of 
best practices, risk factors and interventions specific to this unique population.  A literature 
review was completed in order to help guide survivorship care, as well as identify areas of 
opportunity for further study. A literature review was conducted using Cochrane Database of 
Systematic Reviews (CDSR), CINAHL and PubMed databases.    
 The Cochrane Database of Systematic Reviews (CDSR) was searched first as these 
reviews are considered to have a very strong level of evidence, with well-designed studies and 
rigorous research. The CDSR was searched with the terms breast cancer (27370) AND survivor 
(2862) AND diabetes (52707) resulting in 34 articles to review. Of the 34 results, 17 were 
Cochrane reviews, none of which discussed diabetes in breast cancer survivorship. The 
remaining 17 articles were trials; none of which were relevant for review on this topic.  
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 A search using similar terms was conducted on the PubMed database. The three Mesh 
terms utilized in the search were survivor AND breast neoplasm AND diabetes mellitus resulting 
in 11 articles to review. The search was limited to articles within the last 5 years. Of the 11 
results, 10 were applicable for review. 
 Lastly, a search of Cumulative Index to Nursing and Allied Health Literature (CINAHL) 
was completed. The search terms included were breast cancer AND diabetes AND survivor. 
Initial search resulted in 48 articles for review. The search was limited to publications within the 
last 5 years and peer-reviewed articles. This narrowed the search to 22 articles. Of the 22 articles, 
4 were identified as duplicate results from the PubMed search. Of the remaining 18 articles, 7 
were identified as pertinent to this literature review.   
 Research regarding the connection between cancer and diabetes has focused largely on 
cancer incidence and mortality (Vissers et al., 2016). Connor et al. (2016) found that diabetes 
was a prognostic indicator for all-cause and breast cancer specific mortality among BCS. While 
preexisting diabetes does have an association with increased morbidity and mortality in cancer, 
there is no evidence to suggest that the incidence of cancer has an adverse effect on the long-
term outcomes of patients with diabetes (Griffiths et al., 2017). Much of the existing research 
regarding diabetes in BCS has been focused on various cardiovascular risk factors with diabetes 
as an included variable. Other research has focused on cancer survivors, in general, with BCS as 
a subgroup.  
 Weaver et al. (2013) found that cardiovascular risk factors (such as body mass index, 
physical inactivity, hypercholesterolemia, hypertension, and diabetes) were more common 
among cancer survivors than the general adult population. In another study, diabetes and obesity 
at age 30 were significantly associated with all-cause mortality in all female BCS (Connor et al., 
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2016). Onitilo et al. (2013) provided additional evidence of increased rates of vascular risk 
factors such as kidney disease, heart disease and high blood pressure in BCS and patients with 
diabetes; suggesting the possibility of a “double-hit” in BCS with diabetes. In a study conducted 
regarding the effect of cardiovascular risk factors on long-term prognosis in BCS over the age of 
65, cardiovascular risk factors such as very old age, smoking history, diabetes and hypertension 
were more predictive of CVD risk than breast cancer history alone (Haque et al., 2014). 
Additionally, Qin, Thompson and Silverman (2015) recommended the need for tight glycemic 
control and longer monitoring for cardiac toxicity in diabetic BCS who have received 
anthracycline chemotherapy (a commonly utilized agent in the treatment of breast cancer). The 
BCS with diabetes proved to be at increased risk for late onset anthracycline-induced heart 
failure than BCS without diabetes (Qin et al., 2015). Much improvement could be made to 
improve the overall cardiovascular risk in diabetic BCS with interventions targeting modifiable 
risk factors such as smoking, sedentary lifestyle and obesity.  
 A systemic review found patients with both cancer and diabetes diagnoses scored lower 
on general health-related quality of life, physical functioning and sexual functioning than those 
diagnosed with cancer or diabetes alone (Vissers et al., 2016). Tang et al. (2016) and Jarvandi, 
Perez, Schootman and Jeffe (2016) concluded that a comorbid diagnosis of diabetes specifically 
in BCS was associated with decreased quality of life in comparison to BCS without diabetes. 
Cumulatively, the literature demonstrates enhanced cardiovascular assessment, optimized 
diabetes management as well as interventions to promote positive lifestyle changes in the BCS 
population are necessary to improve long term patient outcomes and quality of life.  
 Some consideration has been taken to analyze possible ethnic differences among diabetic 
BCS. African-American and Hispanic/Latino cancer survivors are more than twice as likely to 
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have comorbidities related to obesity, such as cardiovascular disease and diabetes, than whites 
(Conlon et al., 2015). Ashing, Rosales, Lai & Hurria (2014) examined the occurrence of 
comorbidities among African-American and Latina BCS, with 19% of the sample size endorsing 
a diabetes diagnosis. Chronic conditions, such as diabetes, have been associated with increased 
risk of poor health outcomes among Latina BCS (Ashing et al., 2014). Appropriate and timely 
assessment and management of comorbid conditions in cancer survivors has important 
implications on survival and quality of life (Ashing et al., 2014).  
 Paxton et al. (2013) determined African American BCS have higher rates of comorbid 
conditions, such as diabetes, exacerbated by lack of physical activity and increased sedentary 
behavior. There is a need for intervention focused research to assist African American BCS in 
adopting and maintaining a physical active lifestyle after treatment (Paxton et al., 2013), as well 
as further investigate how this unique population can be best supported after treatment 
(Barsevick et al., 2016). In response to these findings, Black et al. (2018) completed a qualitative 
study in attempts to identify barriers to physical activity in African-American BCS. In order to 
achieve their physical activity goals after treatment, survivors require a multidisciplinary team to 
assist with their psychosocial needs in addition to their physical limitations. 
 A first of its kind, the Bronx Oncology Living Daily (BOLD) Health Living program was 
designed to help cancer survivors prevent and control diabetes. In areas of low socioeconomic 
status, there is limited information and access to cancer screening, treatment and treatment 
options. This intervention was directed towards an underserved community of cancer survivors 
with limited resources to reduce comorbid risk. This short-term lifestyle intervention program for 
cancer survivors was successful in improving health related quality of life and motivating 
participants to improve health behaviors (Conlon et al., 2015). These results are promising 
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evidence to support additional study into effective lifestyle intervention programs aimed at 
improving health status and reducing comorbidity in BCS.  
 Medication compliance in breast cancer survivorship remains a concerning topic. BCS 
have an increased use of long-term medications after the completion of cancer treatment (Loh, 
Ng, Lee, Ng & Chan, 2016). Unfortunately, Yang, Neugut, Wright, Accordino and Hershman 
(2016, p. e802) found that adherence to diabetes medication declined fro 79% to 53.1% in the 
first year after breast cancer treatment. Additional research completed by Calip, Elmore and 
Boudreau (2017) found that 75% of BCS studied were nonadherent in taking prescribed diabetic 
medication. Nonadherence to medications prescribed for chronic conditions is associated with 
increased all-cause mortality, health care cost and hospitalizations (Calip et al., 2017). 
Development of evidence-based interventions to enhance medication adherence, specifically in 
the diabetic BCS population, remains an area of opportunity for additional high-quality research 
(Calip et al., 2017; Loh et al., 2016).  
 Prior research on medication adherence suggests interventions such as collaboration with 
other healthcare providers, assistance with the cost of medications, promoting social support and 
using technology-basted strategies may be successful (Yang et al., 2016). Close collaboration 
between oncology and primary care providers in necessary for effective medication management 
for BCS (Loh et al., 2016). In the future, the development of interventions to address noncancer 
medication adherence after breast cancer treatment should be aimed at mediating factors 
associated increased nonadherence such as older age, insurance type, polypharmacy, and more 
comorbid conditions (Yang et al., 2016). Additional research is required to determine what 
interventions would be the most beneficial for this population (Loh et al., 2016; Yang et al., 
2016). 
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 Throughout the literature there are some common themes regarding the increased 
incidence of cardiovascular risk factors in cancer survivors (Connor et al., 2016; Qin et al., 2015; 
Weaver et al., 2013), the importance intervention to reduce risk through modifiable lifestyle 
factors (Conlon et al., 2015, Paxton et al., 2013), identifying ethnic and socioeconomic variations 
in management (Ashing et al., 2014; Barsevick, 2016), and improving medication adherence of 
BCS with type 2 diabetes (Calip et al., 2017; Loh et al., 2016; Yang et al., 2016). While unique 
needs of BCS with diabetes have been identified, gaps remain in establishing evidence-based 
interventions targeted towards risk reduction and management in this patient population.  
 In a study examining how frequently health care providers were counseling cancer 
survivors with one or more cardiovascular risk factors, only a third of survivors reported having 
a discussion with their healthcare provider regarding health promotion topics such diet, exercise 
and lifestyle change (Weaver et al., 2013). Valid research continues to demonstrate the 
importance of managing preexisting conditions in BCS (Haque et al., 2014). As discussed 
previously, BCS with diabetes require intensified management of comorbid diagnoses. Many 
BCS have modifiable cardiovascular risk factors that need to be addressed. An intervention to 
increase the number of health promotion discussions occurring with diabetic BCS may be an 
important area of further study.  
 The BOLD Healthy Living program offered evidence to support lifestyle intervention 
programs to assist cancer survivors in prevention and control of diabetes (Conlon et al., 2015). 
Implementation of a program with a similar curriculum in diabetic BCS may have similar 
positive results. Development of interventions that coordinate the entire patient care team in the 
management of comorbidities (Ashing et al., 2014) as well as research regarding mental health 
issues, patient empowerment and improving patient self-management of chronic illness may be 
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areas for further study to improve survivorship care in diabetic BCS (Vissers et al., 2016).  
Learning Points 
• Survivorship care of diabetic BCS should focus on effective diabetes management 
(Hauge et al., 2014), identification of modifiable problems (i.e. obesity, inactivity) 
(Barsevick, 2016; Paxton et al., 2013) and supporting positive health changes (Onitilo et 
al., 2013; Weaver et al., 2012).  
• Interventions must incorporative a multidisciplinary treatment team, including primary 
care physicians and oncology specialists, in a coordinated effort to improve management 
of comorbidities in cancer survivors (Ashing et al., 2014).  
• Special consideration for high-risk populations, such as ethnic minorities and low 
socioeconomic classes, could aide in identifying barriers to healthy behaviors and 
individualize health promotion recommendations (Ashing et al., 2014; Barsevick, 2016; 
Conlon et al., 2015; Black et al., 2018; Paxton et al., 2013).  
• Lifestyle intervention programs may help improve health-related quality of life in 
diabetic BCS (Conlon et al., 2015).  
• Interventions to improve medication compliance in diabetic BCS could improve overall 
outcomes (Loh et al., 2016; Yang et al., 2016). 
Conclusion 
 Improvement in screening, diagnosis and treatment of breast cancer in women has lead to 
an increase in the BCS population. BCS with diabetes are more likely to suffer from increased 
morbidity, mortality, and decreased health-related quality of life than BCS without diabetes 
(Barsevick et al., 2016; Jarvancdi et al., 2016; Tang et al., 2016; Vissers et al., 2016). Diabetic 
BCS face unique physical and emotional difficulties in their survivorship journey. BCS with 
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diabetes require individualized support and early risk-factor identification, screening and disease 
management. Further research into interventions specifically regarding emotional and 
multidisciplinary support for sustaining healthy lifestyle change and medication adherence in 
BCS with diabetes, not only could improve morbidity, mortality and quality of life, but also 
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